Eli Lilly and Co announced the issuance of $6.5 billion in new notes, divided into five tranches with varying interest rates and maturity dates. The tranches include $1 billion of 4.500% notes due 2027, $1 billion of 4.500% notes due 2029, $1.5 billion of 4.700% notes due 2034, $1.5 billion of 5.000% notes due 2054, and $1.5 billion of 5.100% notes due 2064. Interest on these notes is payable semi-annually on February 9 and August 9. The notes are unsecured and rank equally with Eli Lilly's other unsecured and unsubordinated debt. The offering involves joint book-running managers Barclays, BofA Securities, Citigroup, Deutsche Bank Securities, and Mizuho, along with co-managers including Academy Securities, CastleOak Securities, L.P., R. Seelaus & Co., LLC, Ramirez & Co., Inc., Cabrera Capital Markets LLC, Independence Point Securities, Loop Capital Markets, Penserra...Show More

Eli Lilly and Co announced the issuance of $6.5 billion in new notes, divided into five tranches with varying interest rates and maturity dates. The tranches include $1 billion of 4.500% notes due 2027, $1 billion of 4.500% notes due 2029, $1.5 billion of 4.700% notes due 2034, $1.5 billion of 5.000% notes due 2054, and $1.5 billion of 5.100% notes due 2064. Interest on these notes is payable semi-annually on February 9 and August 9. The notes are unsecured and rank equally with Eli Lilly's other unsecured and unsubordinated debt. The offering involves joint book-running managers Barclays, BofA Securities, Citigroup, Deutsche Bank Securities, and Mizuho, along with co-managers including Academy Securities, CastleOak Securities, L.P., R. Seelaus & Co., LLC, Ramirez & Co., Inc., Cabrera Capital Markets LLC, Independence Point Securities, Loop Capital Markets, Penserra Securities LLC, and Roberts & Ryan. The proceeds from the sale are intended for general corporate purposes, which may include the repayment of outstanding commercial paper. The announcement specifies that the notes will not be listed on any securities exchange, and the underwriters expect to deliver the notes to investors in book-entry form through The Depository Trust Company on or about February 9, 2024.